Jazz Pharmaceuticals plc Financing Cash Flow
Jazz Pharmaceuticals plc (JAZZ) reported Financing Cash Flow of -$1.07 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-03
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$994.50M.
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$78.50M.
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $75.44M.
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$10.92M, a 104.43% decline year-over-year.
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2025 was -$873.38M, a 4357.07% decline from fiscal 2024.
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2024 was $20.52M.
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2023 was -$305.25M.
- Jazz Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2022 was -$529.49M, a 113.34% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$994.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$1.07B 10-Q · filed 2026-08-03 | -$997.56M derived: sum of 3 quarters · filed 2026-08-03 | -$1.01B derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | -$78.50M 10-Q · filed 2026-05-05 | -$3.06M derived: sum of 2 quarters · filed 2026-05-05 | -$13.98M derived: sum of 3 quarters · filed 2026-05-05 | -$138.38M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | $75.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $64.52M derived: sum of 2 quarters · filed 2026-02-24 | -$59.88M derived: sum of 3 quarters · filed 2026-08-03 | -$873.38M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | -$10.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$135.32M derived: sum of 2 quarters · filed 2026-08-03 | -$948.82M 10-Q · filed 2025-11-05 | -$957.10M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | -$124.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$937.90M 10-Q · filed 2026-08-03 | -$937.99M 10-Q · filed 2025-08-06 | -$946.17M derived: sum of 3 quarters · filed 2026-08-03 | -$699.75M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | -$813.50M 10-Q · filed 2026-05-05 | -$813.47M 10-Q · filed 2025-05-07 | -$821.77M derived: sum of 2 quarters · filed 2026-05-05 | -$575.35M derived: sum of 3 quarters · filed 2026-05-05 | -$736.43M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$8.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $238.15M derived: sum of 2 quarters · filed 2026-02-24 | $77.07M derived: sum of 3 quarters · filed 2026-02-24 | $20.52M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $246.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $85.34M derived: sum of 2 quarters · filed 2025-11-05 | $28.79M 10-Q · filed 2025-11-05 | -$71.52M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | -$161.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$217.64M 10-Q · filed 2025-08-06 | -$317.94M derived: sum of 3 quarters · filed 2026-02-24 | -$396.44M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | -$56.55M 10-Q · filed 2025-05-07 | -$156.86M derived: sum of 2 quarters · filed 2026-02-24 | -$235.35M derived: sum of 3 quarters · filed 2026-02-24 | -$332.02M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | -$100.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$178.80M derived: sum of 2 quarters · filed 2026-02-24 | -$275.47M derived: sum of 3 quarters · filed 2026-02-24 | -$305.25M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | -$78.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$175.16M derived: sum of 2 quarters · filed 2024-11-07 | -$204.95M 10-Q · filed 2024-11-07 | -$185.35M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | -$96.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$126.45M 10-Q · filed 2024-08-01 | -$106.86M derived: sum of 3 quarters · filed 2025-02-26 | -$395.91M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | -$29.79M 10-Q · filed 2024-05-02 | -$10.19M derived: sum of 2 quarters · filed 2025-02-26 | -$299.25M derived: sum of 3 quarters · filed 2025-02-26 | -$288.47M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $19.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$269.46M derived: sum of 2 quarters · filed 2025-02-26 | -$258.68M derived: sum of 3 quarters · filed 2025-02-26 | -$529.49M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$289.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$278.28M derived: sum of 2 quarters · filed 2023-11-08 | -$549.09M 10-Q · filed 2023-11-08 | -$795.70M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $10.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$260.03M 10-Q · filed 2023-08-09 | -$506.64M derived: sum of 3 quarters · filed 2024-02-28 | -$971.82M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$270.81M 10-Q · filed 2023-05-10 | -$517.42M derived: sum of 2 quarters · filed 2024-02-28 | -$982.60M derived: sum of 3 quarters · filed 2024-02-28 | $3.68B derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | -$246.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$711.79M derived: sum of 2 quarters · filed 2024-02-28 | $3.95B derived: sum of 3 quarters · filed 2024-02-28 | $3.97B 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$465.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.20B derived: sum of 2 quarters · filed 2022-11-09 | $4.22B 10-Q · filed 2022-11-09 | $4.27B derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $4.66B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.68B 10-Q · filed 2022-08-03 | $4.74B derived: sum of 3 quarters · filed 2023-03-01 | $4.72B derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $18.28M 10-Q · filed 2022-05-04 | $74.15M derived: sum of 2 quarters · filed 2023-03-01 | $51.50M derived: sum of 3 quarters · filed 2023-03-01 | $694.03M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $55.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $33.22M derived: sum of 2 quarters · filed 2023-03-01 | $675.76M derived: sum of 3 quarters · filed 2023-03-01 | $528.07M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | -$22.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $619.88M derived: sum of 2 quarters · filed 2021-11-09 | $472.19M 10-Q · filed 2021-11-09 | $384.42M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $642.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $494.85M 10-Q · filed 2021-08-03 | $407.07M derived: sum of 3 quarters · filed 2022-03-01 | $387.61M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$147.68M 10-Q · filed 2021-05-04 | -$235.46M derived: sum of 2 quarters · filed 2022-03-01 | -$254.93M derived: sum of 3 quarters · filed 2022-03-01 | -$311.08M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$87.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$107.24M derived: sum of 2 quarters · filed 2022-03-01 | -$163.40M derived: sum of 3 quarters · filed 2022-03-01 | -$293.75M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$19.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$75.62M derived: sum of 2 quarters · filed 2020-11-02 | -$205.97M 10-Q · filed 2020-11-02 | -$652.42M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-06-30 | -$56.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$186.50M 10-Q · filed 2020-08-04 | -$632.96M derived: sum of 3 quarters · filed 2021-02-23 | -$646.93M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-03-31 | -$130.35M 10-Q · filed 2020-05-05 | -$576.80M derived: sum of 2 quarters · filed 2021-02-23 | -$590.78M derived: sum of 3 quarters · filed 2021-02-23 | -$561.90M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2018-12-31 | -$446.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$460.43M derived: sum of 2 quarters · filed 2021-02-23 | -$431.56M derived: sum of 3 quarters · filed 2021-02-23 | -$479.13M 10-K · filed 2021-02-23 | |||
| 2018-09-30 | -$13.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $14.90M derived: sum of 2 quarters · filed 2019-11-05 | -$32.67M 10-Q · filed 2019-11-05 | -$72.66M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $28.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$18.70M 10-Q · filed 2019-08-06 | -$58.69M derived: sum of 3 quarters · filed 2020-02-25 | -$31.66M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | -$47.58M 10-Q · filed 2019-05-07 | -$87.56M derived: sum of 2 quarters · filed 2020-02-25 | -$60.53M derived: sum of 3 quarters · filed 2020-02-25 | -$275.01M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | -$39.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$12.96M derived: sum of 2 quarters · filed 2020-02-25 | -$227.44M derived: sum of 3 quarters · filed 2020-02-25 | -$409.11M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $27.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$187.45M derived: sum of 2 quarters · filed 2018-11-06 | -$369.13M 10-Q · filed 2018-11-06 | -$541.17M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | -$214.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$396.15M 10-Q · filed 2018-08-07 | -$568.20M derived: sum of 3 quarters · filed 2019-02-26 | $327.02M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$181.67M 10-Q · filed 2018-05-08 | -$353.72M derived: sum of 2 quarters · filed 2019-02-26 | $541.51M derived: sum of 3 quarters · filed 2019-02-26 | $511.77M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$172.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $723.18M derived: sum of 2 quarters · filed 2019-02-26 | $693.45M derived: sum of 3 quarters · filed 2019-02-26 | $540.99M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $895.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $865.49M derived: sum of 2 quarters · filed 2017-11-07 | $713.03M 10-Q · filed 2017-11-07 | $589.17M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | -$29.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$182.19M 10-Q · filed 2017-08-08 | -$178.69M 10-Q · filed 2016-08-09 | -$306.05M derived: sum of 3 quarters · filed 2018-02-27 | -$400.48M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | -$152.46M 10-Q · filed 2017-05-09 | -$144.52M 10-Q · filed 2016-05-10 | -$276.32M derived: sum of 2 quarters · filed 2018-02-27 | -$370.74M derived: sum of 3 quarters · filed 2018-02-27 | -$363.52M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | -$123.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$218.28M derived: sum of 2 quarters · filed 2018-02-27 | -$211.06M derived: sum of 3 quarters · filed 2018-02-27 | -$214.32M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | -$94.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$87.20M derived: sum of 2 quarters · filed 2016-11-08 | -$90.46M 10-Q · filed 2016-11-08 | -$100.90M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $7.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.96M 10-Q · filed 2016-08-09 | -$6.48M derived: sum of 3 quarters · filed 2017-02-28 | $256.79M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | -$3.26M 10-Q · filed 2016-05-10 | -$13.70M derived: sum of 2 quarters · filed 2017-02-28 | $249.57M derived: sum of 3 quarters · filed 2017-02-28 | $210.11M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $252.83M derived: sum of 2 quarters · filed 2017-02-28 | $213.37M derived: sum of 3 quarters · filed 2017-02-28 | $711.03M 10-K · filed 2017-02-28 | $712.88M 10-K · filed 2015-02-24 | ||
| 2014-09-30 | $263.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $223.81M derived: sum of 2 quarters · filed 2015-11-09 | $721.47M 10-Q · filed 2015-11-09 | $692.75M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-06-30 | -$39.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $458.21M 10-Q · filed 2015-08-05 | $429.48M derived: sum of 3 quarters · filed 2016-02-23 | $383.76M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-03-31 | $497.66M 10-Q · filed 2015-05-07 | $468.94M derived: sum of 2 quarters · filed 2016-02-23 | $423.22M derived: sum of 3 quarters · filed 2016-02-23 | $470.67M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | -$28.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | -$74.44M derived: sum of 2 quarters · filed 2016-02-23 | -$26.99M derived: sum of 3 quarters · filed 2016-02-23 | -$23.86M 10-K · filed 2016-02-23 | -$24.03M 10-K · filed 2014-02-25 | ||
| 2013-09-30 | -$45.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $1.73M derived: sum of 2 quarters · filed 2014-11-04 | $4.87M 10-Q · filed 2014-11-04 | $8.46M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $47.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $50.59M 10-Q · filed 2014-08-05 | $54.18M derived: sum of 3 quarters · filed 2015-02-24 | $48.69M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $3.13M 10-Q · filed 2014-05-08 | $6.72M derived: sum of 2 quarters · filed 2015-02-24 | $1.24M derived: sum of 3 quarters · filed 2015-02-24 | $469.89M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$1.90M derived: sum of 2 quarters · filed 2015-02-24 | $466.75M derived: sum of 3 quarters · filed 2015-02-24 | $448.53M 10-K · filed 2015-02-24 | |||
| 2012-09-30 | -$5.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $463.17M derived: sum of 2 quarters · filed 2013-11-05 | $444.94M 10-Q · filed 2013-11-05 | $447.74M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $468.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $450.43M 10-Q · filed 2013-08-06 | $453.23M derived: sum of 3 quarters · filed 2014-02-25 | $419.62M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | -$18.23M 10-Q · filed 2013-05-07 | -$15.42M derived: sum of 2 quarters · filed 2014-02-25 | -$49.04M derived: sum of 3 quarters · filed 2014-02-25 | -$48.32M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$30.81M derived: sum of 2 quarters · filed 2014-02-25 | -$30.09M derived: sum of 3 quarters · filed 2014-02-25 | -$33.08M 10-K · filed 2014-02-25 | |||
| 2011-09-30 | -$33.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$32.89M derived: sum of 2 quarters · filed 2012-11-09 | -$35.88M 10-Q · filed 2012-11-09 | -$35.62M derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2011-06-30 | $719.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$2.27M 10-Q · filed 2012-08-07 | -$2.01M derived: sum of 3 quarters · filed 2013-02-26 | -$6.41M derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2011-03-31 | -$2.99M 10-Q · filed 2012-05-08 | -$2.73M derived: sum of 2 quarters · filed 2013-02-26 | -$7.13M derived: sum of 3 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$4.14M derived: sum of 2 quarters · filed 2013-02-26 | -$27.53M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | -$4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$27.79M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | -$23.39M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-31 | $12.69M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |